PRPH, US74345W2070

ProPhase Labs stock fell 10.23 percent on October 6

Published on 10/07/2026 at 05:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

ProPhase Labs stock carried a USD 0.1 million market value on October 6, 2026. Volume reached 25,704 shares while the 52-week high stood at USD 6.70.

PRPH, US74345W2070, Illustration mit AI erstellt.

ProPhase Labs (ISIN US74345W2070) was last at USD 0.01 on Nasdaq on October 6, 2026 at 4:00 p.m. ET, down 10.23 percent. The decline put the stock 99.85 percent below its 52-week high of USD 6.70.

Stock value falls to USD 0.1 million

ProPhase Labs had a market capitalization of USD 0.1 million on October 6, 2026. The same quote showed a 52-week low of USD 0.01 and a 52-week high of USD 6.70, leaving the last price at the bottom of that interval.

Volume reached 25,704 shares on October 6, 2026. The trading figure gives the price move a concrete scale because the company had fewer than 26,000 shares changing hands during the session.

Q2 period ended June 30

ProPhase Labs identifies Q2 2026, the quarter ended June 30, 2026, as its latest financial-results period. Its investor-relations overview describes the company as a biotechnology, genomics and consumer-products business with diagnostics and health-and-wellness operations.

The company profile connects the business to whole-genome sequencing, diagnostic development and direct-to-consumer supplements. For investors, the numerical contrast is stark: the USD 0.01 quote on October 6, 2026 was 99.85 percent below the USD 6.70 52-week high, while the market value stood at USD 0.1 million.

Nasdaq quote remains at USD 0.01

ProPhase Labs stock was last at USD 0.01 on Nasdaq on October 6, 2026 at 4:00 p.m. ET. The session change was negative 10.23 percent, and the quoted volume was 25,704 shares.